These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. Need AC; Keefe RS; Ge D; Grossman I; Dickson S; McEvoy JP; Goldstein DB Eur J Hum Genet; 2009 Jul; 17(7):946-57. PubMed ID: 19156168 [TBL] [Abstract][Full Text] [Related]
14. Ethnic stratification of the association of RGS4 variants with antipsychotic treatment response in schizophrenia. Campbell DB; Ebert PJ; Skelly T; Stroup TS; Lieberman J; Levitt P; Sullivan PF Biol Psychiatry; 2008 Jan; 63(1):32-41. PubMed ID: 17588543 [TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics for the individualization of psychiatric treatment. Arranz MJ; Collier D; Kerwin RW Am J Pharmacogenomics; 2001; 1(1):3-10. PubMed ID: 12173312 [TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of treatment effects in schizophrenia. Stroup TS Am J Med; 2007 Apr; 120(4 Suppl 1):S26-31. PubMed ID: 17403379 [TBL] [Abstract][Full Text] [Related]
17. Treatment response trajectories and antipsychotic medications: examination of up to 18 months of treatment in the CATIE chronic schizophrenia trial. Levine SZ; Rabinowitz J; Faries D; Lawson AH; Ascher-Svanum H Schizophr Res; 2012 May; 137(1-3):141-6. PubMed ID: 22316567 [TBL] [Abstract][Full Text] [Related]
18. Atypical antipsychotic medications and the treatment of schizophrenia. Lewis DA Am J Psychiatry; 2002 Feb; 159(2):177-9. PubMed ID: 11823256 [No Abstract] [Full Text] [Related]
19. Applications of the AMP/AMDP-System to drug trials. Mod Probl Pharmacopsychiatry; 1983; 20():204-10. PubMed ID: 6137767 [No Abstract] [Full Text] [Related]
20. Influence of DAOA gene variants on antipsychotic response after switch to aripiprazole. Pae CU; Chiesa A; Serretti A Psychiatry Res; 2010 Jul; 178(2):430-2. PubMed ID: 20471098 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]